These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 20471487)

  • 21. HOPE-preservation of paraffin-embedded sputum samples--a new way of bioprofiling in COPD.
    Pedersen F; Marwitz S; Seehase S; Kirsten AM; Zabel P; Vollmer E; Rabe KF; Magnussen H; Watz H; Goldmann T
    Respir Med; 2013 Apr; 107(4):587-95. PubMed ID: 23312618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gender differences in the bronchoalveolar lavage cell proteome of patients with chronic obstructive pulmonary disease.
    Kohler M; Sandberg A; Kjellqvist S; Thomas A; Karimi R; Nyrén S; Eklund A; Thevis M; Sköld CM; Wheelock ÅM
    J Allergy Clin Immunol; 2013 Mar; 131(3):743-51. PubMed ID: 23146379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exhaled breath condensate biomarkers in COPD.
    Borrill ZL; Roy K; Singh D
    Eur Respir J; 2008 Aug; 32(2):472-86. PubMed ID: 18669788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breath condensate nitrite correlates with hyperinflation in chronic obstructive pulmonary disease.
    Gessner C; Hammerschmidt S; Kuhn H; Hoheisel G; Gillissen A; Sack U; Wirtz H
    Respir Med; 2007 Nov; 101(11):2271-8. PubMed ID: 17693071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induced sputum in the investigation of airway inflammation of COPD.
    Tsoumakidou M; Tzanakis N; Siafakas NM
    Respir Med; 2003 Aug; 97(8):863-71. PubMed ID: 12924512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired neutrophil chemotaxis in chronic obstructive pulmonary disease.
    Yoshikawa T; Dent G; Ward J; Angco G; Nong G; Nomura N; Hirata K; Djukanovic R
    Am J Respir Crit Care Med; 2007 Mar; 175(5):473-9. PubMed ID: 17110644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Airway biomarkers of the oxidant burden in asthma and chronic obstructive pulmonary disease: current and future perspectives.
    Louhelainen N; Myllärniemi M; Rahman I; Kinnula VL
    Int J Chron Obstruct Pulmon Dis; 2008; 3(4):585-603. PubMed ID: 19281076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma.
    Keatings VM; Collins PD; Scott DM; Barnes PJ
    Am J Respir Crit Care Med; 1996 Feb; 153(2):530-4. PubMed ID: 8564092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood and sputum biomarkers in COPD and asthma: a review.
    Paone G; Leone V; Conti V; De Marchis L; Ialleni E; Graziani C; Salducci M; Ramaccia M; Munafò G
    Eur Rev Med Pharmacol Sci; 2016; 20(4):698-708. PubMed ID: 26957273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monitoring oxidative stress during chronic obstructive pulmonary disease exacerbations using malondialdehyde.
    Antus B; Harnasi G; Drozdovszky O; Barta I
    Respirology; 2014 Jan; 19(1):74-9. PubMed ID: 23834671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repeatability of inflammatory parameters in induced sputum of COPD patients.
    Boorsma M; Lutter R; van de Pol MA; Out TA; Jansen HM; Jonkers RE
    COPD; 2007 Dec; 4(4):321-9. PubMed ID: 18027159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of corticosteroids on noninvasive biomarkers of inflammation in asthma and chronic obstructive pulmonary disease.
    Kharitonov SA; Barnes PJ
    Proc Am Thorac Soc; 2004; 1(3):191-9. PubMed ID: 16113434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biomarkers in chronic obstructive pulmonary disease.
    Sin DD; Vestbo J
    Proc Am Thorac Soc; 2009 Sep; 6(6):543-5. PubMed ID: 19741266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of 8-isoprostane and interleukin-8 in induced sputum and exhaled breath condensate from asymptomatic and symptomatic smokers.
    Mazur W; Stark H; Sovijärvi A; Myllärniemi M; Kinnula VL
    Respiration; 2009; 78(2):209-16. PubMed ID: 19252398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptomics, proteomics and metabolomics driven biomarker discovery in COPD: an update.
    Ghosh N; Dutta M; Singh B; Banerjee R; Bhattacharyya P; Chaudhury K
    Expert Rev Mol Diagn; 2016 Aug; 16(8):897-913. PubMed ID: 27267972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impaired macrophage phagocytosis in non-eosinophilic asthma.
    Simpson JL; Gibson PG; Yang IA; Upham J; James A; Reynolds PN; Hodge S;
    Clin Exp Allergy; 2013 Jan; 43(1):29-35. PubMed ID: 23278878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular mechanisms of inflammation during exacerbations of chronic obstructive pulmonary disease.
    Kersul AL; Iglesias A; Ríos Á; Noguera A; Forteza A; Serra E; Agustí A; Cosío BG
    Arch Bronconeumol; 2011 Apr; 47(4):176-83. PubMed ID: 21454005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Importance of the distal airway in COPD].
    Cosío BG; Rodríguez Rosado J
    Arch Bronconeumol; 2011 Apr; 47 Suppl 2():32-7. PubMed ID: 21640283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytokine-mediated xanthine oxidase upregulation in chronic obstructive pulmonary disease's airways.
    Komaki Y; Sugiura H; Koarai A; Tomaki M; Ogawa H; Akita T; Hattori T; Ichinose M
    Pulm Pharmacol Ther; 2005; 18(4):297-302. PubMed ID: 15777613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Correlations between chymase activity, levels of tryptase, and eotaxin in the sputum of patients with chronic obstructive pulmonary disease and their clinical implications].
    Zhang XJ; He SH; Xie H; Wei JF; Liu CT
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Oct; 27(10):649-53. PubMed ID: 16200864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.